Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT06207786

Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery

Efficacy of Intranasal Povidone Iodine Swab Versus Oral Antibiotic Prophylaxis to Prevent Surgical Site Infections in Patients Undergoing Mohs Micrographic Surgery

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare surgical site infection rates for patients treated with Mohs micrographic surgery after bilateral nasal swab with povidone iodine versus standard treatment including the use of a standardized oral antibiotic prophylaxis protocol.

Conditions

Interventions

TypeNameDescription
OTHERPovidone-Iodine SwabsUndergo nasal swab of both nostrils for 30 seconds into each nostril, allowing two minutes to dry, immediately (e.g. within 30 minutes) prior to performing skin reconstruction.
DIAGNOSTIC_TESTStaphylococcus nasal swabUndergo a nasal swab to identify patients with preoperative nasal Staphylococcus aureus colonization
DRUGAntibioticReceive an oral anti-staphylococcal antibiotic (e.g. oral cephalexin) with standard dosing only if indicated for antibiotic prophylaxis per the Mayo Clinic Dermatologic Surgery Antibiotic Prophylaxis protocol that is currently standard practice for patients undergoing Mohs micrographic surgery (MMS)

Timeline

Start date
2024-09-01
Primary completion
2029-05-01
Completion
2030-05-01
First posted
2024-01-17
Last updated
2024-11-25

Source: ClinicalTrials.gov record NCT06207786. Inclusion in this directory is not an endorsement.

Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery (NCT06207786) · Clinical Trials Directory